Gestational and Developmental Contributors of Pediatric MASLD

Abstract

Pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) is common and can be seen as early as in utero. A growing body of literature suggests that gestational and early life exposures modify the risk of MASLD development in children. These include maternal risk factors, such as poor cardiometabolic health (e.g., obesity, gestational diabetes, rapid weight gain during pregnancy, and MASLD), as well as periconceptional dietary exposures, degree of physical activity, intestinal microbiome, and smoking. Paternal factors, such as diet and obesity, also appear to play a role. Beyond gestation, early life dietary exposures, as well as the rate of infant weight gain, may further modify the risk of future MASLD development. The mechanisms linking parental health and environmental exposures to pediatric MASLD are complex and not entirely understood. In conclusion, investigating gestational and developmental contributors to MASLD is critical and may identify future interventional targets for disease prevention.

Keywords

NAFLD - fatty liver - pregnancy - children - diet

Publikationsverlauf

Artikel online veröffentlicht:
29. Februar 2024

• References

• 1 Yu EL, Schwimmer JB. Epidemiology of pediatric nonalcoholic fatty liver disease. Clin Liver Dis (Hoboken) 2021; 17 (03) 196-199
• 2 Modi N, Murgasova D, Ruager-Martin R. et al. The influence of maternal body mass index on infant adiposity and hepatic lipid content. Pediatr Res 2011; 70 (03) 287-291
• 3 Brumbaugh DE, Tearse P, Cree-Green M. et al. Intrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes. J Pediatr 2013; 162 (05) 930-936.e1
• 4 Hoofnagle JH, Doo E, Ratziu V. et al. Letter to the editor: a multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 2023; 78 (06) 1966-1986
• 5 Doycheva I, Issa D, Watt KD, Lopez R, Rifai G, Alkhouri N. Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in young adults in the United States. J Clin Gastroenterol 2018; 52 (04) 339-346
• 6 Vos MB, Abrams SH, Barlow SE. et al. NASPGHAN Clinical Practice Guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 2017; 64 (02) 319-334
• 7 Draijer L, Voorhoeve M, Troelstra M. et al. A natural history study of paediatric non-alcoholic fatty liver disease over 10 years. JHEP Rep Innov Hepatol 2023; 5 (05) 100685
• 8 Xanthakos SA, Lavine JE, Yates KP. et al; NASH Clinical Research Network. Progression of fatty liver disease in children receiving standard of care lifestyle advice. Gastroenterology 2020; 159 (05) 1731-1751.e10
• 9 Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009; 58 (11) 1538-1544
• 10 Hagström H, Stål P, Hultcrantz R, Hemmingsson T, Andreasson A. Overweight in late adolescence predicts development of severe liver disease later in life: a 39 years follow-up study. J Hepatol 2016; 65 (02) 363-368
• 11 Suomela E, Oikonen M, Pitkänen N. et al. Childhood predictors of adult fatty liver. The cardiovascular risk in Young Finns Study. J Hepatol 2016; 65 (04) 784-790
• 12 Goyal NP, Schwimmer JB. The genetics of pediatric nonalcoholic fatty liver disease. Clin Liver Dis 2018; 22 (01) 59-71
• 13 Mansoor S, Maheshwari A, Di Guglielmo M. et al. The PNPLA3 rs738409 variant but not MBOAT7 rs641738 is a risk factor for nonalcoholic fatty liver disease in obese U.S. children of Hispanic ethnicity. Pediatr Gastroenterol Hepatol Nutr 2021; 24 (05) 455-469
• 14 Lim GEH, Tang A, Ng CH. et al. An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD. Clin Gastroenterol Hepatol 2023; 21 (03) 619-629.e7
• 15 Putri RR, Casswall T, Hagman E. Risk and protective factors of non-alcoholic fatty liver disease in paediatric obesity: a nationwide nested case-control study. Clin Obes 2022; 12 (02) e12502
• 16 Iwaki M, Kobayashi T, Nogami A, Saito S, Nakajima A, Yoneda M. Impact of sarcopenia on non-alcoholic fatty liver disease. Nutrients 2023; 15 (04) 891
• 17 Bae-Gartz I, Kasper P, Großmann N. et al. Maternal exercise conveys protection against NAFLD in the offspring via hepatic metabolic programming. Sci Rep 2020; 10 (01) 15424
• 18 Barbour LA, Hernandez TL. Maternal lipids and fetal overgrowth: making fat from fat. Clin Ther 2018; 40 (10) 1638-1647
• 19 De Souza LR, Berger H, Retnakaran R. et al. Non-alcoholic fatty liver disease in early pregnancy predicts dysglycemia in mid-pregnancy: prospective study. Am J Gastroenterol 2016; 111 (05) 665-670
• 20 Easton ZJW, Regnault TRH. The impact of maternal body composition and dietary fat consumption upon placental lipid processing and offspring metabolic health. Nutrients 2020; 12 (10) 3031
• 21 Hernandez TL. 352-OR: Maternal triglycerides in gestational diabetes are strongly associated with increased newborn hepatic fat independent of subcutaneous fat. Diabetes 2019; 68 (Suppl. 01) 352-OR
• 22 McCurdy CE, Bishop JM, Williams SM. et al. Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 2009; 119 (02) 323-335
• 23 Patel KR, White FV, Deutsch GH. Hepatic steatosis is prevalent in stillborns delivered to women with diabetes mellitus. J Pediatr Gastroenterol Nutr 2015; 60 (02) 152-158
• 24 Zhou Y, Peng H, Xu H. et al. Maternal diet intervention before pregnancy primes offspring lipid metabolism in liver. Lab Invest 2020; 100 (04) 553-569
• 25 Fisher SC, Kim SY, Sharma AJ, Rochat R, Morrow B. Is obesity still increasing among pregnant women? Prepregnancy obesity trends in 20 states, 2003-2009. Prev Med 2013; 56 (06) 372-378
• 26 Singh GK, Siahpush M, Hiatt RA, Timsina LR. Dramatic increases in obesity and overweight prevalence and body mass index among ethnic-immigrant and social class groups in the United States, 1976-2008. J Community Health 2011; 36 (01) 94-110
• 27 Ayonrinde OT, Adams LA, Mori TA. et al. Sex differences between parental pregnancy characteristics and nonalcoholic fatty liver disease in adolescents. Hepatology 2018; 67 (01) 108-122
• 28 Bedogni G, De Matteis G, Fabrizi M. et al. Association of bright liver with the PNPLA3 I148M gene variant in 1-year-old toddlers. J Clin Endocrinol Metab 2019; 104 (06) 2163-2170
• 29 Bellatorre A, Scherzinger A, Stamm E, Martinez M, Ringham B, Dabelea D. Fetal overnutrition and adolescent hepatic fat fraction: the exploring perinatal outcomes in children study. J Pediatr 2018; 192: 165-170.e1
• 30 Patel S, Lawlor DA, Callaway M, Macdonald-Wallis C, Sattar N, Fraser A. Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease. BMC Pediatr 2016; 16: 47
• 31 Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34 (03) 274-285
• 32 Mosca A, Panera N, Maggiore G, Alisi A. From pregnant women to infants: non-alcoholic fatty liver disease is a poor inheritance. J Hepatol 2020; 73 (06) 1590-1592
• 33 Hagström H, Höijer J, Ludvigsson JF. et al. Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease. Liver Int 2016; 36 (02) 268-274
• 34 Lee SM, Kwak SH, Koo JN. et al. Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus. Diabetologia 2019; 62 (02) 238-248
• 35 Gross A, Lange M, Rosenbluth E. et al. Evaluation of 2-year outcomes in infants born to mothers with and without NAFLD in pregnancy. Eur J Pediatr 2023; 182 (08) 3765-3774
• 36 Ferchaud-Roucher V, Barner K, Jansson T, Powell TL. Maternal obesity results in decreased syncytiotrophoblast synthesis of palmitoleic acid, a fatty acid with anti-inflammatory and insulin-sensitizing properties. FASEB J 2019; 33 (05) 6643-6654
• 37 Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005; 115 (05) 1343-1351
• 38 McCormick KL, Susa JB, Widness JA, Singer DB, Adamsons K, Schwartz R. Chronic hyperinsulinemia in the fetal rhesus monkey: effects on hepatic enzymes active in lipogenesis and carbohydrate metabolism. Diabetes 1979; 28 (12) 1064-1068
• 39 Kim SR, Kubo T, Kuroda Y. et al. Comparative metabolome analysis of cultured fetal and adult hepatocytes in humans. J Toxicol Sci 2014; 39 (05) 717-723
• 40 Calabuig-Navarro V, Haghiac M, Minium J. et al. Effect of maternal obesity on placental lipid metabolism. Endocrinology 2017; 158 (08) 2543-2555
• 41 Calabuig-Navarro V, Puchowicz M, Glazebrook P. et al. Effect of ω-3 supplementation on placental lipid metabolism in overweight and obese women. Am J Clin Nutr 2016; 103 (04) 1064-1072
• 42 Gázquez A, Prieto-Sánchez MT, Blanco-Carnero JE. et al. In vivo kinetic study of materno-fetal fatty acid transfer in obese and normal weight pregnant women. J Physiol 2019; 597 (19) 4959-4973
• 43 Puri P, Baillie RA, Wiest MM. et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007; 46 (04) 1081-1090
• 44 Roberts KA, Riley SC, Reynolds RM. et al. Placental structure and inflammation in pregnancies associated with obesity. Placenta 2011; 32 (03) 247-254
• 45 Aye IL, Lager S, Ramirez VI. et al. Increasing maternal body mass index is associated with systemic inflammation in the mother and the activation of distinct placental inflammatory pathways. Biol Reprod 2014; 90 (06) 129
• 46 Jones HN, Jansson T, Powell TL. IL-6 stimulates system A amino acid transporter activity in trophoblast cells through STAT3 and increased expression of SNAT2. Am J Physiol Cell Physiol 2009; 297 (05) C1228-C1235
• 47 Chambers MA, Moylan JS, Smith JD, Goodyear LJ, Reid MB. Stretch-stimulated glucose uptake in skeletal muscle is mediated by reactive oxygen species and p38 MAP-kinase. J Physiol 2009; 587 (Pt 13): 3363-3373
• 48 Tsai RY, Tai YH, Tzeng JI. et al. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats and prevents glutamate transporter downregulation by suppressing the p38 mitogen-activated protein kinase signaling pathway. Neuroscience 2009; 159 (04) 1244-1256
• 49 Herath MP, Beckett JM, Hills AP, Byrne NM, Ahuja KDK. Gestational diabetes mellitus and infant adiposity at birth: a systematic review and meta-analysis of therapeutic interventions. J Clin Med 2021; 10 (04) 835
• 50 Wiechers C, Balles LS, Kirchhof S. et al. Body composition in term offspring after maternal gestational diabetes does not predict postnatal hypoglycemia. BMC Pediatr 2021; 21 (01) 111
• 51 Castillo-Laura H, Santos IS, Quadros LC, Matijasevich A. Maternal obesity and offspring body composition by indirect methods: a systematic review and meta-analysis. Cad Saude Publica 2015; 31 (10) 2073-2092
• 52 LaBarre JL, Puttabyatappa M, Song PXK. et al. Maternal lipid levels across pregnancy impact the umbilical cord blood lipidome and infant birth weight. Sci Rep 2020; 10 (01) 14209
• 53 Cohen CC, Francis EC, Perng W. et al. Exposure to maternal fuels during pregnancy and offspring hepatic fat in early childhood: the healthy start study. Pediatr Obes 2022; 17 (07) e12902
• 54 van der Pligt PF, Kuswara K, McNaughton SA. et al. Maternal diet quality and associations with plasma lipid profiles and pregnancy-related cardiometabolic health. Eur J Nutr 2023; 62 (08) 3369-3381
• 55 Wankhade UD, Zhong Y, Kang P. et al. Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations. PLoS One 2017; 12 (04) e0175675
• 56 Li H, Fang Q, Gao F. et al. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. J Hepatol 2010; 53 (05) 934-940
• 57 Mouralidarane A, Soeda J, Sugden D. et al. Maternal obesity programs offspring non-alcoholic fatty liver disease through disruption of 24-h rhythms in mice. Int J Obes 2015; 39 (09) 1339-1348
• 58 Soeda J, Cordero P, Li J. et al. Hepatic rhythmicity of endoplasmic reticulum stress is disrupted in perinatal and adult mice models of high-fat diet-induced obesity. Int J Food Sci Nutr 2017; 68 (04) 455-466
• 59 Suter MA, Ma J, Vuguin PM. et al. In utero exposure to a maternal high-fat diet alters the epigenetic histone code in a murine model. Am J Obstet Gynecol 2014; 210 (05) 463.e1-463.e11
• 60 Zhang J, Zhang F, Didelot X. et al. Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring. BMC Genomics 2009; 10: 478
• 61 Benatti RO, Melo AM, Borges FO. et al. Maternal high-fat diet consumption modulates hepatic lipid metabolism and microRNA-122 (miR-122) and microRNA-370 (miR-370) expression in offspring. Br J Nutr 2014; 111 (12) 2112-2122
• 62 Strakovsky RS, Zhang X, Zhou D, Pan YX. Gestational high fat diet programs hepatic phosphoenolpyruvate carboxykinase gene expression and histone modification in neonatal offspring rats. J Physiol 2011; 589 (Pt 11): 2707-2717
• 63 Aagaard-Tillery KM, Grove K, Bishop J. et al. Developmental origins of disease and determinants of chromatin structure: maternal diet modifies the primate fetal epigenome. J Mol Endocrinol 2008; 41 (02) 91-102
• 64 Saad AF, Dickerson J, Kechichian TB. et al. High-fructose diet in pregnancy leads to fetal programming of hypertension, insulin resistance, and obesity in adult offspring. Am J Obstet Gynecol 2016; 215 (03) 378.e1-378.e6
• 65 Starling AP, Sauder KA, Kaar JL, Shapiro AL, Siega-Riz AM, Dabelea D. Maternal dietary patterns during pregnancy are associated with newborn body composition. J Nutr 2017; 147 (07) 1334-1339
• 66 Sloboda DM, Li M, Patel R, Clayton ZE, Yap C, Vickers MH. Early life exposure to fructose and offspring phenotype: implications for long term metabolic homeostasis. J Obes 2014; 2014: 203474
• 67 Thorn SR, Baquero KC, Newsom SA. et al. Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primates. Diabetes 2014; 63 (08) 2702-2713
• 68 Alfaradhi MZ, Fernandez-Twinn DS, Martin-Gronert MS, Musial B, Fowden A, Ozanne SE. Oxidative stress and altered lipid homeostasis in the programming of offspring fatty liver by maternal obesity. Am J Physiol Regul Integr Comp Physiol 2014; 307 (01) R26-R34
• 69 Sen S, Simmons RA. Maternal antioxidant supplementation prevents adiposity in the offspring of Western diet-fed rats. Diabetes 2010; 59 (12) 3058-3065
• 70 Grant WF, Gillingham MB, Batra AK. et al. Maternal high fat diet is associated with decreased plasma n-3 fatty acids and fetal hepatic apoptosis in nonhuman primates. PLoS One 2011; 6 (02) e17261
• 71 Gutierrez Sanchez LH, Tomita K, Guo Q. et al. Perinatal nutritional reprogramming of the epigenome promotes subsequent development of nonalcoholic steatohepatitis. Hepatol Commun 2018; 2 (12) 1493-1512
• 72 Thompson MD, Cismowski MJ, Trask AJ. et al. Enhanced steatosis and fibrosis in liver of adult offspring exposed to maternal high-fat diet. Gene Expr 2016; 17 (01) 47-59
• 73 Ideraabdullah FY, Belenchia AM, Rosenfeld CS. et al. Maternal vitamin D deficiency and developmental origins of health and disease (DOHaD). J Endocrinol 2019; JOE-18-0541.R2
• 74 Bison A, Marchal-Bressenot A, Li Z. et al. Foetal programming by methyl donor deficiency produces steato-hepatitis in rats exposed to high fat diet. Sci Rep 2016; 6: 37207
• 75 Hinrichs H, Faerber A, Young M, Ballentine SJ, Thompson MD. Maternal exercise protects male offspring from maternal diet-programmed nonalcoholic fatty liver disease progression. Endocrinology 2023; 164 (03) bqad010
• 76 Stevanović-Silva J, Beleza J, Coxito P. et al. Exercise performed during pregnancy positively modulates liver metabolism and promotes mitochondrial biogenesis of female offspring in a rat model of diet-induced gestational diabetes. Biochim Biophys Acta Mol Basis Dis 2022; 1868 (11) 166526
• 77 De Jesus DF, Orime K, Kaminska D. et al. Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice. J Clin Invest 2020; 130 (05) 2391-2407
• 78 Akhavan Rezayat A, Dadgar Moghadam M, Ghasemi Nour M. et al. Association between smoking and non-alcoholic fatty liver disease: a systematic review and meta-analysis. SAGE Open Med 2018; 6: 2050312117745223
• 79 Yuan H, Shyy JY, Martins-Green M. Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1. J Hepatol 2009; 51 (03) 535-547
• 80 Lin J, Gu W, Huang H. Effects of paternal obesity on fetal development and pregnancy complications: a prospective clinical cohort study. Front Endocrinol (Lausanne) 2022; 13: 826665
• 81 de Castro Barbosa T, Alm PS, Krook A, Barrès R, Zierath JR. Paternal high-fat diet transgenerationally impacts hepatic immunometabolism. FASEB J 2019; 33 (05) 6269-6280
• 82 Terashima M, Barbour S, Ren J, Yu W, Han Y, Muegge K. Effect of high fat diet on paternal sperm histone distribution and male offspring liver gene expression. Epigenetics 2015; 10 (09) 861-871
• 83 Watkins AJ, Dias I, Tsuro H. et al. Paternal diet programs offspring health through sperm- and seminal plasma-specific pathways in mice. Proc Natl Acad Sci U S A 2018; 115 (40) 10064-10069
• 84 Zhang X, Dong Y, Sun G. et al. Paternal programming of liver function and lipid profile induced by a paternal pre-conceptional unhealthy diet: potential association with altered gut microbiome composition. Kidney Blood Press Res 2019; 44 (01) 133-148
• 85 Querter I, Pauwels NS, De Bruyne R. et al. Maternal and perinatal risk factors for pediatric nonalcoholic fatty liver disease: a systematic review. Clin Gastroenterol Hepatol 2022; 20 (04) 740-755
• 86 Newton KP, Feldman HS, Chambers CD. et al; Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN). Low and high birth weights are risk factors for nonalcoholic fatty liver disease in children. J Pediatr 2017; 187: 141-146.e1
• 87 Nobili V, Marcellini M, Marchesini G. et al. Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children. Diabetes Care 2007; 30 (10) 2638-2640
• 88 Nobili V, Bedogni G, Alisi A. et al. A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease. Arch Dis Child 2009; 94 (10) 801-805
• 89 Smith EVL, Dyson RM, Berry MJ, Gray C. Fructose consumption during pregnancy influences milk lipid composition and offspring lipid profiles in guinea pigs. Front Endocrinol (Lausanne) 2020; 11: 550
• 90 Toyama T, Nakamura H, Harano Y. et al. PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. Biochem Biophys Res Commun 2004; 324 (02) 697-704
• 91 Wu Y, Chen W, Guo M. et al. Metabolomics of extracellular vesicles: a future promise of multiple clinical applications. Int J Nanomedicine 2022; 17: 6113-6129
• 92 Jiang X, Wu Y, Zhong H. et al. Human milk-derived extracellular vesicles alleviate high fat diet-induced non-alcoholic fatty liver disease in mice. Mol Biol Rep 2023; 50 (03) 2257-2268
• 93 Reif S, Atias A, Musseri M, Koroukhov N, Gerstl RG. Beneficial effects of milk-derived extracellular vesicles on liver fibrosis progression by inhibiting hepatic stellate cell activation. Nutrients 2022; 14 (19) 4049
• 94 Rogier EW, Frantz AL, Bruno ME. et al. Lessons from mother: long-term impact of antibodies in breast milk on the gut microbiota and intestinal immune system of breastfed offspring. Gut Microbes 2014; 5 (05) 663-668
• 95 Yelverton CA, Killeen SL, Feehily C. et al. Maternal breastfeeding is associated with offspring microbiome diversity; a secondary analysis of the MicrobeMom randomized control trial. Front Microbiol 2023; 14: 1154114
• 96 Breij LM, Kerkhof GF, Hokken-Koelega AC. Accelerated infant weight gain and risk for nonalcoholic fatty liver disease in early adulthood. J Clin Endocrinol Metab 2014; 99 (04) 1189-1195
• 97 Faienza MF, Brunetti G, Ventura A. et al. Nonalcoholic fatty liver disease in prepubertal children born small for gestational age: influence of rapid weight catch-up growth. Horm Res Paediatr 2013; 79 (02) 103-109
• 98 Ribas-Aulinas F, Ribo S, Parra-Vargas M. et al. Neonatal overfeeding during lactation rapidly and permanently misaligns the hepatic circadian rhythm and programmes adult NAFLD. Mol Metab 2021; 45: 101162
• 99 Soderborg TK, Clark SE, Mulligan CE. et al. The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD. Nat Commun 2018; 9 (01) 4462
• 100 Soderborg TK, Clark SE, Mulligan CE. et al. Author correction: the gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD. Nat Commun 2019; 10 (01) 2965
• 101 Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Clément K. Metabolism and metabolic disorders and the microbiome: the intestinal microbiota associated with obesity, lipid metabolism, and metabolic health-pathophysiology and therapeutic strategies. Gastroenterology 2021; 160 (02) 573-599
• 102 Wankhade UD, Zhong Y, Kang P. et al. Maternal high-fat diet programs offspring liver steatosis in a sexually dimorphic manner in association with changes in gut microbial ecology in mice. Sci Rep 2018; 8 (01) 16502
• 103 Guo Q, Tang Y, Li Y. et al. Perinatal high-salt diet induces gut microbiota dysbiosis, bile acid homeostasis disbalance, and NAFLD in weanling mice offspring. Nutrients 2021; 13 (07) 2135
• 104 Jonscher KR, Abrams J, Friedman JE. Maternal diet alters trained immunity in the pathogenesis of pediatric NAFLD. J Cell Immunol 2020; 2 (06) 315-325